A human study to evaluate the improvement effectiveness of Seapolynol (Ecklonia cava extract) on postprandial glucose level in healthy subjects.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0002206

Enrollment

Registered

2017-01-31

Start date

2017-01-20

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Subject who voluntarily agree to participate and signs informed consent form at visit1(-1week) are diagnosed whether they are suitable or not by inclusive and exclusive criteria.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subject who voluntarily agree to participate and signs informed consent form 2) 20 years= Age <70 years (Ratio of men and women 1:1) 3) Fasting blood glucose><126mg>/dL 4) Subject who comply with dietary/exercise guidlines for intervention period

Exclusion criteria

Exclusion criteria: 1) Continuous consumption of drug that affect glucose metabolism, inflammation, antioxidative capacity and lipid metabolism or dietary supplement or oriental medicine within 4 weeks before the first visit 2) Consumption of anticoagulant within 4 weeks before the first visit 3) BMI=18.5 or BMI=30 4) Following diseases : ? Diabetes, liver dysfunction, renal dysfunction, cardiovascular diseases (hypertension(= 140/90 mmHg), stroke, etc.), thyroid diseases ? Mental diseases such as depression, schizophrenia, alcoholism , drug addiction ? Wasting diseases such as malignant tumor etc., and severe muscular skeletal disease ? asthma and allergic diseases 5) Chronic smoker (= 20 cigarettes / day) 6) Excessive exercise (= 10 hours / week) 7) Subjects who controlling body weight or subjects who have changed of body weight more than 4kg within 4 weeks before the first visit 8) Recommended Food Score > 36 9) Subjects with hypersensitivity to test materials 10) Participation in other human study within 4 weeks before the first visit 11) Pregnant or lactating women 12) Any condition that the principal investigator believes may put the subjects at undue risk

Design outcomes

Primary

Measure	Time frame
Glucose, insulin etc	—

Secondary

Measure	Time frame
Height, weight, BMI etc	—

Countries

Korea, Republic of

Contacts

Public ContactYunsoo Kim

Ewha Womans University

sookim726@gmail.com+82-2-3277-3087

Outcome results